IS THERE ANY DIFFERENCE IN RA PATIENTS FOR METHOTREXATE USE VS. LEFLUNOMIDE USE AS A CONCOMITANT TREATMENT WITH BIOLOGICAL AND TARGETED SYNTHETIC DMARDS IN TURKBIO REGISTRY?
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.611-612, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 77
- Doi Number: 10.1136/annrheumdis-2018-eular.5662
- City: Amsterdam
- Country: Netherlands
- Page Numbers: pp.611-612
- Istanbul University Affiliated: Yes